Literature DB >> 19139949

Association of complementary or alternative medicine use with quality of life, functional status or cumulated damage in chronic rheumatic diseases.

José Alvarez-Nemegyei1, Alberta Bautista-Botello, Jorge Dávila-Velázquez.   

Abstract

Quality of life, functional status, or cumulated damage were compared between users and non-users of complementary and alternative medicine (CAM) in 445 rheumatic patients (rheumatoid arthritis [RA]: 64; systemic lupus erythematosus [SLE]: 192; fibromyalgia [FM]: 34; and knee osteoarthritis [KOA]: 155). CAM use was reported by 249 subjects (55.9%; 95%CI; 51.4-60.6). After a general linear model was applied, CAM use was associated with lower scores in the physical function (p = 0.02) and bodily pain (p = 0.03) domains of the SF-36 survey. In FM, RA and KOA, functional status was not different between users and non-users. CAM use was associated with higher cumulated damage (p = 0.04) in SLE. In patients with chronic rheumatic diseases, CAM use was not associated with better quality of life. Additionally, in SLE patients, CAM use was associated with higher cumulated damage. More research on CAM use in chronic rheumatic diseases is needed to better delineate its risk/benefit profile.

Entities:  

Mesh:

Year:  2009        PMID: 19139949     DOI: 10.1007/s10067-008-1082-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

Review 1.  Epidemiology of complementary and alternative practices in rheumatology.

Authors:  C Ramos-Remus; S Gutierrez-Ureña; P Davis
Journal:  Rheum Dis Clin North Am       Date:  1999-11       Impact factor: 2.670

2.  [Evaluation of health status using Survey SF-36: preliminary results in Mexico].

Authors:  M A Zúniga; G T Carrillo-Jiménez; P J Fos; B Gandek; M R Medina-Moreno
Journal:  Salud Publica Mex       Date:  1999 Mar-Apr

Review 3.  Herbal remedies.

Authors:  Peter A G M De Smet
Journal:  N Engl J Med       Date:  2002-12-19       Impact factor: 91.245

4.  The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group.

Authors:  A D Moore; M A Petri; S Manzi; D A Isenberg; C Gordon; J L Senécal; Y St Pierre; L Joseph; J Penrod; P R Fortin; N Sutcliffe; J R Goulet; D Choquette; T Grodzicky; J M Esdaile; A E Clarke
Journal:  Arthritis Rheum       Date:  2000-06

Review 5.  Current role of glucosamine in the treatment of osteoarthritis.

Authors:  J-Y Reginster; O Bruyere; A Neuprez
Journal:  Rheumatology (Oxford)       Date:  2007-03-31       Impact factor: 7.580

Review 6.  Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects.

Authors:  Arathi R Setty; Leonard H Sigal
Journal:  Semin Arthritis Rheum       Date:  2005-06       Impact factor: 5.532

7.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

8.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

Review 10.  Complementary and alternative approaches to the treatment of persistent musculoskeletal pain.

Authors:  Debra K Weiner; Edzard Ernst
Journal:  Clin J Pain       Date:  2004 Jul-Aug       Impact factor: 3.442

View more
  6 in total

Review 1.  Treatment of lupus: impact on quality of life.

Authors:  Sergio M A Toloza; Winston Sequeira; Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

Review 2.  A critical review of complementary and alternative medicine use among people with arthritis: a focus upon prevalence, cost, user profiles, motivation, decision-making, perceived benefits and communication.

Authors:  Lu Yang; David Sibbritt; Jon Adams
Journal:  Rheumatol Int       Date:  2016-11-26       Impact factor: 2.631

Review 3.  Pitfalls and opportunities in measuring patient outcomes in lupus.

Authors:  Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

Review 4.  Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues.

Authors:  Sergio M A Toloza; Meenakshi Jolly; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

5.  Factors associated with the use of complementary therapies in Taiwanese patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  Ming-Chi Lu; Hui-Chin Lo; Hsiu-Hua Chang; Chia-Wen Hsu; Malcolm Koo
Journal:  BMC Complement Med Ther       Date:  2021-10-01

6.  Prevalence of complementary and alternative medicine despite limited perceived efficacy in patients with rheumatic diseases in Mexico: Cross-sectional study.

Authors:  Claudia Isabel Caballero-Hernández; Susana Aideé González-Chávez; Adelfia Urenda-Quezada; Greta Cristina Reyes-Cordero; Ingris Peláez-Ballestas; Everardo Álvarez-Hernández; César Pacheco-Tena
Journal:  PLoS One       Date:  2021-09-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.